Watanabe Y - Search Results

1

Improved anti-cancer effect of interferon gene transfer by sustained expression using CpG-reduced plasmid DNA.

Kawano H, Nishikawa M, Mitsui M, Takahashi Y, Kako K, Yamaoka K, Watanabe Y, Takakura Y. Kawano H, et al. Among authors: watanabe y. Int J Cancer. 2007 Jul 15;121(2):401-6. doi: 10.1002/ijc.22636. Int J Cancer. 2007. PMID: 17372909

2

Therapeutic effect of intravenous interferon gene delivery with naked plasmid DNA in murine metastasis models.

Kobayashi N, Kuramoto T, Chen S, Watanabe Y, Takakura Y. Kobayashi N, et al. Among authors: watanabe y. Mol Ther. 2002 Dec;6(6):737-44. doi: 10.1006/mthe.2002.0803. Mol Ther. 2002. PMID: 12498770 Free article.

3

Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model.

Sakurai F, Terada T, Maruyama M, Watanabe Y, Yamashita F, Takakura Y, Hashida M. Sakurai F, et al. Among authors: watanabe y. Cancer Gene Ther. 2003 Sep;10(9):661-8. doi: 10.1038/sj.cgt.7700617. Cancer Gene Ther. 2003. PMID: 12944985

4

Enhancement of antiproliferative activity of interferons by RNA interference-mediated silencing of SOCS gene expression in tumor cells.

Takahashi Y, Kaneda H, Takasuka N, Hattori K, Nishikawa M, Watanabe Y, Takakura Y. Takahashi Y, et al. Among authors: watanabe y. Cancer Sci. 2008 Aug;99(8):1650-5. doi: 10.1111/j.1349-7006.2008.00850.x. Cancer Sci. 2008. PMID: 18754879 Free PMC article.

5

Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression.

Mitsui M, Nishikawa M, Zang L, Ando M, Hattori K, Takahashi Y, Watanabe Y, Takakura Y. Mitsui M, et al. Among authors: watanabe y. J Gene Med. 2009 May;11(5):435-43. doi: 10.1002/jgm.1317. J Gene Med. 2009. PMID: 19291673

6

Prolonged circulation half-life of interferon γ activity by gene delivery of interferon γ-serum albumin fusion protein in mice.

Miyakawa N, Nishikawa M, Takahashi Y, Ando M, Misaka M, Watanabe Y, Takakura Y. Miyakawa N, et al. Among authors: watanabe y. J Pharm Sci. 2011 Jun;100(6):2350-7. doi: 10.1002/jps.22473. Epub 2011 Jan 18. J Pharm Sci. 2011. PMID: 21246562

7

Constant and steady transgene expression of interferon-γ by optimization of plasmid construct for safe and effective interferon-γ gene therapy.

Ando M, Takahashi Y, Nishikawa M, Watanabe Y, Takakura Y. Ando M, et al. Among authors: watanabe y. J Gene Med. 2012 Apr;14(4):288-95. doi: 10.1002/jgm.2616. J Gene Med. 2012. PMID: 22359360

8

Gene delivery of albumin binding peptide-interferon-gamma fusion protein with improved pharmacokinetic properties and sustained biological activity.

Miyakawa N, Nishikawa M, Takahashi Y, Ando M, Misaka M, Watanabe Y, Takakura Y. Miyakawa N, et al. Among authors: watanabe y. J Pharm Sci. 2013 Sep;102(9):3110-8. doi: 10.1002/jps.23493. Epub 2013 Mar 5. J Pharm Sci. 2013. PMID: 23463584

9

Enhancement of anticancer effect of interferon-γ gene transfer against interferon-γ-resistant tumor by depletion of tumor-associated macrophages.

Kiyota T, Takahashi Y, Watcharanurak K, Nishikawa M, Ohara S, Ando M, Watanabe Y, Takakura Y. Kiyota T, et al. Among authors: watanabe y. Mol Pharm. 2014 May 5;11(5):1542-9. doi: 10.1021/mp4007216. Epub 2014 Apr 7. Mol Pharm. 2014. PMID: 24708139

10

Secretion polarity of interferon-beta in epithelial cell lines.

Nakanishi K, Watanabe Y, Maruyama M, Yamashita F, Takakura Y, Hashida M. Nakanishi K, et al. Among authors: watanabe y. Arch Biochem Biophys. 2002 Jun 15;402(2):201-7. doi: 10.1016/S0003-9861(02)00093-0. Arch Biochem Biophys. 2002. PMID: 12051664

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,122 results

Search Page

Filters